APA

Duiker E. W., de Vries E. G. E., Mahalingam D., Meersma G. J., Boersma-van Ek W., Hollema H., Lub-de Hooge M. N., van Dam G. M., Cool R. H., Quax W. J., Samali A., van der Zee A. G. J. & de Jong S. (20090416). Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Duiker Evelien W, de Vries Elisabeth G E, Mahalingam Devalingam, Meersma Gert Jan, Boersma-van Ek Wytske, Hollema Harry, Lub-de Hooge Marjolijn N, van Dam Go M, Cool Robbert H, Quax Wim J, Samali Afshin, van der Zee Ate G J and de Jong Steven. 20090416. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Duiker E. W., de Vries E. G. E., Mahalingam D., Meersma G. J., Boersma-van Ek W., Hollema H., Lub-de Hooge M. N., van Dam G. M., Cool R. H., Quax W. J., Samali A., van der Zee A. G. J. and de Jong S. (20090416). Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Duiker Evelien W, de Vries Elisabeth G E, Mahalingam Devalingam, Meersma Gert Jan, Boersma-van Ek Wytske, Hollema Harry, Lub-de Hooge Marjolijn N, van Dam Go M, Cool Robbert H, Quax Wim J, Samali Afshin, van der Zee Ate G J and de Jong Steven. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20090416.